The LENISNA product was designed as a filler that acts over time, with a concentration of 170 mg of polylactic acid PDLLA and 30 mg of non-cross-linked hyaluronic acid.
By adjusting the amount of solution and the particle size from 50 to 60 micrometers and combining them with non-cross-linked hyaluronic acid, a hybrid was obtained adapted for application into the subcutaneous tissue or periosteum.
It is intended for theof deep wrinkles, laxity and significant tissue defects.
Lenisna stimulates the production of collagen, which is responsible for skin firmness and tension. Thanks to this, we obtain the effect of young and firm skin.
Lenisna is a combination of polylactic acid PDLLA and hyaluronic acid HA, thanks to which we obtain an effect visible immediately after the.
The filling lasts until the production of new collagen by poly D,L lactic acid begins to dominate.
Lenisna has the ability to strongly and long-lastingly stimulate collagen production and restore a youthful appearance, gradually and naturally.
The world’s only Poly D,L Lactyd + HA hybrid formula, with a particle size of 50 to 60 micrometers
Efficacy and safety confirmed by clinical trials
Durability of effects – over 2 years from the last
Immediate effect – due to hyaluronic acid
Safety – FDA, CE certificates for polylactic acid
Patents and own clinical trials
Particle size from 50 to 60 micrometers
Comfort of the procedure – easy injection and no needle clogging during the procedure
Patents
Patent: No. 10-1481441 – method of producing polymer microparticles with a network structure, which allows for connection with non-cross-linked hyaluronic acid, which is a carrier for PDLLA acid
Patent: No. 10-1725279 – process of obtaining polylactic acid microparticles by spraying, spherical, porous shape.
Reviews
There are no reviews yet